Pre-emptive analgesia before and during elective painful procedures should be given to all neonates which often includes a combination of non-pharmacologic and pharmacologic techniques.
Non-pharmacologic approaches (for use for minor procedures including heel prick, venepuncture and venous canulation):
- Oral sucrose (see sucrose guideline)
- Breastfeeding
- Kangaroo care
- Non-nutritive sucking
- Swaddling
- Facilitated tuck (maintaining arms and legs in a flexed position)
Topical anaesthetics:
Lidocaine should be infiltrated in the skin prior to procedures such as chest drain insertion.
Systemic analgesia:
Opioids are the most effective therapy for moderate to severe pain in patients of all ages. They provide both analgesia and sedation, have a wide therapeutic window, and also attenuate physiologic stress responses. The most commonly used is morphine sulphate. Ventilated neonates should not routinely receive morphine sulphate infusions as this can lead to longer periods of ventilation and slower weaning of feeds. Morphine sulphate should be considered in neonates who appear to be in pain due to an identified cause (NEC, post-operatively). Although data are limited morphine analgesia may be beneficial in term infants following birth asphyxia, and is standard practice for any cooled infant. MRI scans have been shown to demonstrate less brain injury in infants with HIE treated with opioids than those who did not receive opioid therapy. It should also be noted that chest drain removal can be almost as painful as insertion, therefore consider a bolus of morphine prior to chest drain removal. It is standard practice for infants who are paralysed to be given morphine for sedation/pain relief.
Paracetamol can be considered in the management of mild to moderate procedural and post operative pain. This is administered orally or rarely by other routes after discussion with a consultant. See paracetamol guideline for dosing.
Adjunctive treatments:
Midazolam is a short-acting benzodiazepine which provides sedation, anxiolysis, muscle relaxation and amnesia. It does not provide analgesia and may even mask the clinical signs of pain in some neonates. There are limited data that midazolam is associated with an increase in poor neurological outcome among preterm neonates. It should be considered in neonates who continue to display distress due to an identifiable cause despite adequate pain control e.g. distress from pleural effusions.